X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-01 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $39.03 | -1,168 | 19,157 | -6% | -$45,586 | |||||
| D | 2023-04-03 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $23.34 | -5,000 | 16,992 | -23% | -$116,718 | |||||
| D | 2023-02-10 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $23.75 | -2,392 | 19,492 | -11% | -$56,806 | |||||
| D | 2023-01-31 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $24.68 | -3,244 | 15,081 | -18% | -$80,069 | |||||
| D | 2023-01-03 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $25.82 | -10,000 | 9,992 | -50% | -$258,183 | |||||
| D | 2022-10-06 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $19.69 | -3,557 | 12,492 | -22% | -$70,044 | |||||
| D | 2022-08-04 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $20.00 | -5,000 | 5,897 | -46% | -$100,000 | |||||
| D | 2022-07-11 | KDNY | King Andrew James | Chief Scientific Officer | S - Sale+OE | $18.09 | -5,000 | 5,897 | -46% | -$90,468 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |